Articles related to COGNITIVE HEALTH/MEMORY

This comprehensive overview of dementia symptoms provides physicians with a practical framework for patient education and early detection. By recognizing these signs early, healthcare providers can initiate timely interventions and support strategies to enhance patient care.

Approximately one in four patients without observable responses to commands demonstrated cognitive activity on fMRI or EEG, suggesting a higher prevalence of covert consciousness than previously recognized.

Zunveyl, a prodrug of galantamine, has been formulated to minimize gastrointestinal absorption, potentially addressing common tolerability issues associated with acetylcholinesterase inhibitors in Alzheimer’s treatment.

Amantadine emerges as the pharmacologic agent with the most support for improving cognitive impairment after TBI, while cognitive rehabilitation interventions demonstrate substantial evidence for enhancing neurocognitive function and reducing functional limitations.

A phase 3 clinical trial of buntanetap in early Parkinson’s disease patients demonstrated improvements in motor and cognitive functions, particularly in those with longer disease duration and postural instability.

LANS presents with memory symptoms that mimic Alzheimer’s disease, but brain imaging and biomarkers indicate a different underlying condition, potentially leading to more accurate diagnoses and prognoses for older adults with cognitive decline.